Technology
Health
Pharmaceutical

Forty Seven

$12.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.08%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Forty Seven and other stocks, options, ETFs, and crypto commission-free!

About

Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. Read More The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.

Employees
57
Headquarters
Menlo Park, California
Founded
2014
Market Cap
380.59M
Price-Earnings Ratio
Dividend Yield
Average Volume
154.45K
High Today
$12.32
Low Today
$12.06
Open Price
$12.23
Volume
46.43K
52 Week High
$23.83
52 Week Low
$10.50

Collections

Technology
Health
Pharmaceutical
Cancer Prevention
Medical
2018 IPO
US
North America

News

Yahoo FinanceMay 13

Forty Seven Inc. Reports First Quarter 2019 Financial Results and Recent Business Highlights

-- Updated Data from Phase 1b/2 Trial of 5F9 in Combination with Rituximab in r/r NHL to be Presented at EHA and ICML in June -- – Updated Data from Phase 1b Trial of 5F9 as Monotherapy and in Combination with Azacitidine in AML and MDS to be Presented at ASCO and EHA in June -- -- Entered into Collaborations with Roche/Genentech and AstraZeneca/Acerta to Evaluate Two Triplet Regimens in NHL -- -- Management to Host Conference Call at 4:30 p.m. ET Today -- MENLO PARK, Calif., May 13, 2019 (GLOBE N...

885
Yahoo FinanceMay 13

Forty Seven, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 13, 2019 / Forty Seven, Inc. (NASDAQ: FTSV) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 13, 2019 at 4:30 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/C-EDEC062026DBF To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company's profile. About Investor Network In...

121
Markets InsiderMay 6

Forty Seven Inc. to Report First Quarter 2019 Financial Results on Monday, May 13, 2019

MENLO PARK, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that it will host a live conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on Monday, May 13, 2019 to report its first quarter 2019 financial results and provide a corporate update. The live call may be accessed by dialing (866) 953-0780 for domestic callers or (630) 652-...

95

Earnings

-$0.74
-$0.67
-$0.61
-$0.54
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.63 per share
Actual
-$0.74 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.